We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$1.23B
AUM Growth
+$240M
Cap. Flow
+$116M
Cap. Flow %
9.38%
Top 10 Hldgs %
61.25%
Holding
137
New
51
Increased
28
Reduced
20
Closed
23

Top Buys

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$70.5M
2
CELG
Celgene Corp
CELG
+$37.6M
3
RPRX
Repros Therapeutics Inc.
RPRX
+$27.9M
4
TSRO
TESARO, Inc.
TSRO
+$21.7M
5
QCOR
QUESTCOR PHARMA INC
QCOR
+$19.9M

Top Sells

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$106M
2
BIIB icon
Biogen
BIIB
+$49.8M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$31.3M
4
STML
Stemline Therapeutics, Inc.
STML
+$16.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 76.94%
2 Financials 0.01%
3 Consumer Staples 0.01%
4 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGEN icon
76
PUT
Repligen
RGEN
$6.91B
$757K 0.06%
+68,300
New +$680K
NSPH
77
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$679K 0.06%
+16,975
New +$847K
FRTX
78
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$500K 0.04%
+127
New +$953K
ASTX
79
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
$400K 0.03%
47,098
-1,602,325
-97% -$10.1M
MBOT icon
80
Microbot Medical
MBOT
$112M
$389K 0.03%
143
– –
GRCE
81
Grace Therapeutics
GRCE
$33.8M
$366K 0.03%
+322
New +$479K
HTWR
82
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$366K 0.03%
+5,000
New +$426K
NAVB
83
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$309K 0.03%
+5,825
New +$340K
XNPT
84
DELISTED
XENOPORT, INC.
XNPT
$274K 0.02%
+48,250
New +$252K
FURX
85
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$220K 0.02%
+5,000
New +$207K
CNC icon
86
Centene
CNC
$30.5B
$151K 0.01%
+9,420
New +$136K
EHC icon
87
Encompass Health
EHC
$11.3B
$144K 0.01%
5,267
+4,393
+503% +$113K
CYH icon
88
Community Health Systems
CYH
$382M
$142K 0.01%
+4,132
New +$147K
AZN icon
89
AstraZeneca
AZN
$269B
$140K 0.01%
+2,700
New +$136K
OCR
90
DELISTED
OMNICARE INC
OCR
$140K 0.01%
2,525
+2,100
+494% +$112K
LPNT
91
DELISTED
LifePoint Health, Inc.
LPNT
$140K 0.01%
+2,995
New +$143K
MD icon
92
Pediatrix Medical
MD
$2.2B
$138K 0.01%
2,750
+2,300
+511% +$112K
HNGR
93
DELISTED
Hanger Inc.
HNGR
$138K 0.01%
4,080
+3,450
+548% +$115K
MGLN
94
DELISTED
Magellan Health Services, Inc.
MGLN
$137K 0.01%
2,290
+1,925
+527% +$112K
AMSG
95
DELISTED
Amsurg Corp
AMSG
$136K 0.01%
3,415
+2,850
+504% +$111K
ALR
96
DELISTED
Alere Inc
ALR
$135K 0.01%
4,430
+3,630
+454% +$111K
AET
97
DELISTED
Aetna Inc
AET
$133K 0.01%
2,070
-110,755
-98% -$7.1M
CVS icon
98
CVS Health
CVS
$135B
$131K 0.01%
+2,300
New +$137K
DVA icon
99
DaVita
DVA
$15.5B
$131K 0.01%
+2,310
New +$132K
WOOF
100
DELISTED
VCA Inc.
WOOF
$129K 0.01%
4,715
+3,935
+504% +$110K
2 3
4
5 6

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Perceptive Advisors held 137 positions worth $1.23B, up 24% from $992M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Perceptive Advisors deployed $116M of net new capital in Q3 2013, opening 51 new positions and adding to 28 existing holdings. Its largest new stake was ONYX PHARMACEUTICALS INC: 556,944 shares worth $69.5M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 80% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Aegerion Pharmaceuticals, an estimated $106M trimmed.

  • Perceptive Advisors's largest Q3 2013 buy was ONYX PHARMACEUTICALS INC: 556,944 shares worth $69.5M.
  • Perceptive Advisors added most to Celgene Corp in Q3 2013, an estimated $37.6M increase.
  • Perceptive Advisors's biggest Q3 2013 reduction was Aegerion Pharmaceuticals, cutting an estimated $106M.
  • Perceptive Advisors fully exited Biogen in Q3 2013, selling an estimated $49.8M.
  • Perceptive Advisors's ten largest holdings make up 61% of its $1.23B portfolio in Q3 2013.
  • Perceptive Advisors opened 51 new positions and closed 23 in Q3 2013.
  • Perceptive Advisors's portfolio value rose 24% quarter-over-quarter to $1.23B.

Based on Perceptive Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.